Milestone Scientific (MLSS) Non-Current Assets (2010 - 2026)
Milestone Scientific (MLSS) posted Non-Current Assets of $610309.0 for Q1 2026, up 85.73% sequentially from $328595.0 in Q4 2025, and up 31.79% YoY from $463090.0 in Q1 2025.
Milestone Scientific (MLSS) Non-Current Assets (2010 - 2026) Analysis & Trends
Milestone Scientific has reported Non-Current Assets for 17 years, with the latest figure at $610309.0 in Q1 2026.
- Quarterly Non-Current Assets rose 31.79% year-over-year to $610309.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 11.56% YoY) and the FY2025 annual result came in at $328595.0, down 35.63% from the prior year.
- Non-Current Assets improved to $610309.0 in Q1 2026 per MLSS's latest filing, from $328595.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $1.4 million in Q3 2023 and troughed at -$2.0 million in Q2 2022.
- A 5-year average of $476211.5 and a median of $538733.0 in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets slumped 310.75% in 2022, then jumped 143.32% in 2023.
- Over 5 years, Non-Current Assets stood at $731582.0 in 2022, then fell by 21.12% to $577043.0 in 2023, then fell by 11.53% to $510518.0 in 2024, then tumbled by 35.63% to $328595.0 in 2025, then surged by 85.73% to $610309.0 in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $610309.0, $328595.0, and $375922.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Milestone Scientific | 41.18 Mn | 38.57 Mn | 1.56 Mn | 610,309.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 610,309.00 |
| Dec 31, 2025 | 328,595.00 |
| Sep 30, 2025 | 375,922.00 |
| Jun 30, 2025 | 420,002.00 |
| Mar 31, 2025 | 463,090.00 |
| Dec 31, 2024 | 510,518.00 |
| Sep 30, 2024 | 476,267.00 |
| Jun 30, 2024 | 511,641.00 |
| Mar 31, 2024 | 538,733.00 |
| Dec 31, 2023 | 577,043.00 |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 871,436.00 |
| Mar 31, 2023 | 692,063.00 |
| Dec 31, 2022 | 731,582.00 |
| Sep 30, 2022 | 763,514.00 |
| Jun 30, 2022 | -2.01 Mn |
| Mar 31, 2022 | 837,574.00 |
| Dec 31, 2021 | 875,993.00 |
| Sep 30, 2021 | 918,156.00 |
| Jun 30, 2021 | 954,492.00 |